Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice.

Story-Roller E, Maggioncalda EC, Lamichhane G.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00614-19. doi: 10.1128/AAC.00614-19. Print 2019 Aug.


Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro.

Story-Roller E, Maggioncalda EC, Lamichhane G.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02613-18. doi: 10.1128/AAC.02613-18. Print 2019 Apr.


Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities.

Story-Roller E, Maggioncalda EC, Cohen KA, Lamichhane G.

Front Microbiol. 2018 Sep 25;9:2273. doi: 10.3389/fmicb.2018.02273. eCollection 2018. Review.


Have we realized the full potential of β-lactams for treating drug-resistant TB?

Story-Roller E, Lamichhane G.

IUBMB Life. 2018 Sep;70(9):881-888. doi: 10.1002/iub.1875. Epub 2018 Jun 22. Review.


Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.

Schwartz M, Fisher S, Story-Roller E, Lamichhane G, Parrish N.

Microb Drug Resist. 2018 Oct;24(8):1191-1197. doi: 10.1089/mdr.2017.0286. Epub 2018 Jan 25.


In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.

Kaushik A, Ammerman NC, Tasneen R, Story-Roller E, Dooley KE, Dorman SE, Nuermberger EL, Lamichhane G.

J Antimicrob Chemother. 2017 Aug 1;72(8):2320-2325. doi: 10.1093/jac/dkx152.


Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.

Kaushik A, Gupta C, Fisher S, Story-Roller E, Galanis C, Parrish N, Lamichhane G.

Future Microbiol. 2017 May;12:473-480. doi: 10.2217/fmb-2016-0234. Epub 2017 Feb 16.


Supplemental Content

Loading ...
Support Center